Jeffrey A. Speir, Ussama M. Abdel-Motal, Mikael Jondal, Ian A. Wilson 

Slides:



Advertisements
Similar presentations
Volume 11, Issue 8, Pages (August 2003)
Advertisements

Structure of the Rho Family GTP-Binding Protein Cdc42 in Complex with the Multifunctional Regulator RhoGDI  Gregory R. Hoffman, Nicolas Nassar, Richard.
Molecular Mechanism of Antibody-Mediated Activation of β-galactosidase
Volume 8, Issue 12, Pages (December 2000)
Crystal Structure of the Tandem Phosphatase Domains of RPTP LAR
Thor Seneca Thorsen, Rachel Matt, William I. Weis, Brian K. Kobilka 
Volume 8, Issue 3, Pages (March 1998)
Crystallographic Structure of SurA, a Molecular Chaperone that Facilitates Folding of Outer Membrane Porins  Eduard Bitto, David B. McKay  Structure 
Volume 14, Issue 3, Pages (March 2001)
Volume 24, Issue 5, Pages (December 2006)
Volume 14, Issue 9, Pages (September 2006)
Volume 124, Issue 1, Pages (January 2006)
Volume 124, Issue 2, Pages (January 2006)
Volume 11, Issue 8, Pages (August 2003)
Volume 25, Issue 2, Pages (February 2017)
Volume 99, Issue 1, Pages (October 1999)
Volume 14, Issue 1, Pages (January 2001)
Volume 4, Issue 3, Pages (March 1996)
Crystal Structure at 2.8 Å of an FcRn/Heterodimeric Fc Complex
Volume 22, Issue 1, Pages (January 2005)
Volume 15, Issue 1, Pages (January 2007)
Molecular Basis of Lysosomal Enzyme Recognition: Three-Dimensional Structure of the Cation-Dependent Mannose 6-Phosphate Receptor  David L Roberts, Daniel.
Crystal Structure of the MHC Class I Homolog MIC-A, a γδ T Cell Ligand
Crystal Structure of the Human High-Affinity IgE Receptor
Hong Ye, Young Chul Park, Mara Kreishman, Elliott Kieff, Hao Wu 
Andrew H. Huber, W.James Nelson, William I. Weis  Cell 
Volume 10, Issue 2, Pages (August 2002)
The Crystal Structure of the Costimulatory OX40-OX40L Complex
Structure of the Human IgE-Fc Cε3-Cε4 Reveals Conformational Flexibility in the Antibody Effector Domains  Beth A. Wurzburg, Scott C. Garman, Theodore.
Daniel Peisach, Patricia Gee, Claudia Kent, Zhaohui Xu  Structure 
Qian Steven Xu, Rebecca B. Kucera, Richard J. Roberts, Hwai-Chen Guo 
Volume 22, Issue 2, Pages (February 2005)
Volume 7, Issue 4, Pages (October 1997)
Volume 14, Issue 5, Pages (May 2006)
Molecular Mechanism of Lipopeptide Presentation by CD1a
Volume 7, Issue 2, Pages (February 1999)
Volume 25, Issue 11, Pages e4 (November 2017)
Volume 6, Issue 6, Pages (December 2000)
Claude Daniel, Stephen Horvath, Paul M Allen  Immunity 
Volume 15, Issue 6, Pages (December 2001)
How a Single T Cell Receptor Recognizes Both Self and Foreign MHC
Volume 12, Issue 3, Pages (March 2000)
Volume 11, Issue 8, Pages (August 2003)
Structure of the Rho Family GTP-Binding Protein Cdc42 in Complex with the Multifunctional Regulator RhoGDI  Gregory R. Hoffman, Nicolas Nassar, Richard.
The Shaping of T Cell Receptor Recognition by Self-Tolerance
Volume 11, Issue 2, Pages (February 2003)
Volume 34, Issue 3, Pages (May 2009)
Volume 31, Issue 6, Pages (December 2009)
Volume 10, Issue 1, Pages (January 1999)
NSF N-Terminal Domain Crystal Structure
Carl C. Correll, Betty Freeborn, Peter B. Moore, Thomas A. Steitz  Cell 
The Crystal Structure of an Unusual Processivity Factor, Herpes Simplex Virus UL42, Bound to the C Terminus of Its Cognate Polymerase  Harmon J Zuccola,
The 2.0 å structure of a cross-linked complex between snowdrop lectin and a branched mannopentaose: evidence for two unique binding modes  Christine Schubert.
Volume 87, Issue 7, Pages (December 1996)
Crystal Structure of the Flagellar σ/Anti-σ Complex σ28/FlgM Reveals an Intact σ Factor in an Inactive Conformation  Margareta K. Sorenson, Soumya S.
Pingwei Li, Gerry McDermott, Roland K. Strong  Immunity 
Structure of CD94 Reveals a Novel C-Type Lectin Fold
Luc Bousset, Hassan Belrhali, Joël Janin, Ronald Melki, Solange Morera 
Volume 25, Issue 6, Pages e5 (June 2019)
Peter König, Rafael Giraldo, Lynda Chapman, Daniela Rhodes  Cell 
Crystal Structures of Two I-Ad–Peptide Complexes Reveal That High Affinity Can Be Achieved without Large Anchor Residues  C.A Scott, P.A Peterson, L Teyton,
Volume 9, Issue 12, Pages (December 2001)
Molecular Mechanism of Antibody-Mediated Activation of β-galactosidase
Volume 9, Issue 6, Pages (December 1998)
Volume 4, Issue 3, Pages (March 1996)
The Crystal Structure of an Unusual Processivity Factor, Herpes Simplex Virus UL42, Bound to the C Terminus of Its Cognate Polymerase  Harmon J Zuccola,
Structural Basis for Activation of ARF GTPase
Volume 16, Issue 3, Pages (March 2002)
Volume 11, Issue 10, Pages (October 2003)
Volume 111, Issue 9, Pages (November 2016)
Presentation transcript:

Crystal Structure of an MHC Class I Presented Glycopeptide that Generates Carbohydrate-Specific CTL  Jeffrey A. Speir, Ussama M. Abdel-Motal, Mikael Jondal, Ian A. Wilson  Immunity  Volume 10, Issue 1, Pages 51-61 (January 1999) DOI: 10.1016/S1074-7613(00)80006-0

Figure 1 Glycosylated MHC I Peptide Epitopes and Glycolipids Tested for Carbohydrate-Specific T Cell Generation and Recognition (A) Sequence of glycosylated viral peptides of H-2Db (top two) or H-2Kb (bottom two). The amino acids replaced by chemical linkers (H, homocysteine-ethylene; S, serine; C, cysteine-ethylene) are denoted by the arrows connected to the attached carbohydrates. The term “homocysteine” will refer to the homocysteine-ethylene linker throughout. The primary anchor residues of each peptide are underlined. Glycopeptide names are given as the first three amino acids of the carrier peptide and its residue length, followed by the linker position and type, then the coupled carbohydrate abbreviation. Thus, ASN9-4H-Gal2 is the Db nonapeptide with galabiose (Gal-α(1,4)Gal-β) coupled to position 4 via a homocysteine linker. (B) Structures of the three types of chemical linkers, which are conjugated with galabiose in this illustration. The glycopeptides shown are, from top to bottom, RGY8-6H-Gal2, ASN9-4H-Gal2, and CRG9-1C-Gal2. (C) Chemical structures of selected glycolipids synthesized with the same carbohydrate moieties present in the glycopeptides; they are, from top to bottom, Gal2-bisulfone, CD77-bisulfone, Lactose-bisulfone, and GM3-lactam ceramide. Immunity 1999 10, 51-61DOI: (10.1016/S1074-7613(00)80006-0)

Figure 2 Glycopeptide Electron Density in the H-2Kb Binding Groove (A) Shaken (McRee 1993), σA-weighted (Read 1986) Fo-Fc map contoured at 1.5σ. The map was computed before refinement of the glycopeptide model; the final coordinates colored by atom type (C, yellow; O, red; N, cyan; S, green) are shown in the electron density. (B) Final shaken and σA-weighted 2Fo-Fc map contoured at 1σ. A 2.5 Å cover radius has been applied to the density in both maps. Atom O6′ is out of view behind the terminal galactose in this view. Immunity 1999 10, 51-61DOI: (10.1016/S1074-7613(00)80006-0)

Figure 3 The H-2Kb Glycopeptide Complex Structure and Comparison with Other MHC I–Bound Peptides and Modeled Glycopeptides (A) The Kb/RGY8-6H-Gal2 crystal structure showing the glycopeptide colored by atom type (see Figure 2) and MHC α1α2 superdomain (residues 1–180) in light gray viewed from the side and (B) along the peptide binding groove. (C) A model derived from the crystal structure in which only very small rotations about the HggP6 linker torsion angles dramatically change the level of TCR access to the carbohydrate (compare to B). (D) The greater size and exposure of the carbohydrate component of RGY8-6H-Gal2 shown in comparison with other MHC I peptide ligands (the PDB accession codes and references are given in Experimental Procedures). The superpostions are the result of aligning only the Cα atoms of the MHC α1α2 domains and then comparing the positions of the bound peptides. RGY8-6H-Gal2 is yellow. The other human MHC I bound peptides are: purple, HLA-A2/Influenza M1; cyan, HLA-B8/HIV1 GAG 7r; green, HLA-B53/HIV2 GAG; and pink, HLA-B35/HIV1 NEF. (E) A similar comparison of RGY8-6H-Gal2 (yellow) with other murine MHC I bound peptides: red, Ld/QL9; magenta, Db/Infl NP; and light green, Kb/SEV-9. (F) A model of Db-bound ASN9-6H-Gal2 superimposed with RGY8-6H-Gal2. Immunity 1999 10, 51-61DOI: (10.1016/S1074-7613(00)80006-0)

Figure 4 The Proposed Relationship between Peptide Glycan Structure and Specfic TCR Recognition In this model, the α/β TCR simultaneously binds the MHC, peptide, and glycan, whereas the γ/δ TCR binds only the glycan. The highest positions reached by the MHC α1 and α2 helices are represented by the helical ribbons in the background. The glycans are assumed to be substituted for single, central, and outward pointing peptide residues and to have nearly fully extended conformations. The glycans shown represent (from left to right) H-galabiose, H-CD77, and H-GM3-lactam on a Kb bound 8-mer, and H-galabiose and H-CD77 on a Db-bound 9-mer (see Figure 1). The extent of exposure (vertical axis) is correlated with generation of reactive CTL (horizontal axis) as outlined in Table 1 and Abdel-Motal et al. 1996. Note that high glycan exposure does not necessarily guarantee good immunogenicity since α/β TCR corecognition of the pMHC is disfavored and the glycan is less likely to have a defined antigenic structure outside of the MHC binding groove suitable for γ/δ TCR recognition. Immunity 1999 10, 51-61DOI: (10.1016/S1074-7613(00)80006-0)